Skip to main content

Neurochemistry of Autism

  • Chapter
  • First Online:
Neurochemical Mechanisms in Disease

Part of the book series: Advances in Neurobiology ((NEUROBIOL,volume 1))

Abstract

Autism is a neurodevelopmental disorder characterized by presence of social deficits, language abnormalities, stereotypies, and repetitive behavior. Brain pathology is extensive, suggesting widespread dysfunction of neurotransmitter systems. Genetic, biochemical, and gene association studies have shown that a number of neurotransmitters including serotonin, dopamine, oxytocin, GABA and glutamate, and acetylcholine contribute to the pathology of autism. Pharmacological treatment of autism has focused on reduction of symptoms and atypical antipsychotics, antidepressants, mood stabilizers, and anticonvulsants have been shown to successfully reduce many symptoms of autism. In this review we discuss the contributions of neurotransmitter systems to the pathology of autism and pharmacological treatment of autistic symptoms associated with neurochemical dysfunction.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Acosta MT, Pearl PL (2003) The neurobiology of autism: new pieces of the puzzle. Curr Neurol Neurosci Rep 3:149–156

    Article  PubMed  Google Scholar 

  • Amara SG, Pacholczyk T (1991) Sodium-dependent neurotransmitter reuptake systems. Curr Opin Neurobiol 1:84–90

    Article  PubMed  CAS  Google Scholar 

  • American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. APA Press, Washington, DC

    Google Scholar 

  • Anderson GM (2005) Serotonin in autism. In: Bauman ML, Kemper TL (eds) The Neurobiology of Autism. Johns Hopkins University Press, Baltimore, MD, pp 303–318

    Google Scholar 

  • Anderson GM, Freedman DX, Cohen DJ, Volkmar FR, Hoder EL, McPhedran P, Minderaa RB, Hansen CR, Young JG (1987) Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry 28:885–900

    Article  PubMed  CAS  Google Scholar 

  • Bailey A, Phillips W, Rutter M (1996) Autism: towards an integration of clinical, genetic, neuropsychological and neurobiological perspectives. J Child Psychol Psychiatry 37:89–126

    Article  PubMed  CAS  Google Scholar 

  • Bauman ML, Kemper TL (1994) Neuroanatomic observations of the brain in autism. In: Bauman ML, Kemper TL (eds) The neurobiology of autism. Johns Hopkins University Press, Baltimore, MD, pp 19–145

    Google Scholar 

  • Bauman ML, Kemper TL (2005) Structural brain anatomy in autism: what is the evidence? In: Bauman ML, Kemper TL (eds) The neurobiology of autism. Johns Hopkins University Press, Baltimore, MD, pp 121–135

    Google Scholar 

  • Beninger RJ, Banasikowski TJ (2008) Dopaminergic mechanism of reward-related incentive learning: focus on the dopamine D(3) receptor. Neurotox Res 14:57–70

    Article  PubMed  CAS  Google Scholar 

  • Berger M, Gray JA, Roth BL (2009) The expanded biology of serotonin. Annu Rev Med 60:355–366

    Article  PubMed  CAS  Google Scholar 

  • Binnie CD (1993) Significance and management of transitory cognitive impairment due to subclinical EEG discharges in children. Brain Dev 15:23–30

    Article  PubMed  CAS  Google Scholar 

  • Blatt GJ, Fitzgerald CM, Guptill JT, Booker AB, Kemper TL, Bauman ML (2001) Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J Autism Dev Disord 31:537–544

    Article  PubMed  CAS  Google Scholar 

  • Bonora E, Beyer KS, Lamb JA, Parr JR, Klauck SM, Benner A, Paolucci M, Abbott A, Ragoussis I, Poustka A, Bailey AJ, Monaco AP (2003) International Molecular Genetic Study of Autism (IMGSAC). Analysis of reelin as a candidate gene for autism. Mol Psychiatry 10:885–892

    Article  CAS  Google Scholar 

  • Boulougouris V, Tsaltas. E (2008) Serotonergic and dopaminergic modulation of attentional processes. Prog Brain Res 172:517–542

    Article  PubMed  CAS  Google Scholar 

  • Bowery NG (2000) GABAB receptors structure and function. In: Martin DL, Olsen RW (eds) GABA in the nervous system: the view at fifty years. Lippincott Williams and Wilkins, Philadelphia, PA, pp 233–244

    Google Scholar 

  • Brandon NJ, Smart TG, Moss SJ (2000) Regulation of GABAA Receptors by protein phosphorylation. In: Martin DL, Olsen RW (eds) GABA in the nervous system: the view at fifty years. Lippincott Williams and Wilkins, Philadelphia, PA, pp 191–206

    Google Scholar 

  • Butkevich IP, Khozhai LI, Mikhailenko VA, Otellin VA (2003) Decreased serotonin level during pregnancy alters morphological and functional characteristics of tonic nociceptive system in juvenile offspring of the rat. Reprod Biol Endocrinol 1:96

    Article  PubMed  Google Scholar 

  • Campbell M, Armenteros JL, Malone RP, Adams PB, Eisenberg ZW, Overall JE (1997) Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study. J Am Acad Child Adolesc Psychiatry 36:835–843

    Article  PubMed  CAS  Google Scholar 

  • Canitano R, Scandurra V (2008) Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents. Neuropsychiatr Dis Treat 4:723–730

    PubMed  CAS  Google Scholar 

  • Carlson NR (2001) Physiology of behavior. Allyn and Bacon, Boston, MA

    Google Scholar 

  • Chez MG, Aimonovitch M, Buchanan T, Mrazek S, Tremb RJ (2004) Treating autistic spectrum disorders in children: utility of the cholinesterase inhibitor rivastigmine tartrate. J Child Neurol 19:165–169

    PubMed  Google Scholar 

  • Choleris E, Gustafsson JA, Korach KS, Muglia LJ, Pfaff DW, Ogawa S (2003) An estrogen-dependent four-gene micronet regulating social recognition: a study with oxytocin and estrogen receptor-alpha and -beta knockout mice. Proc Natl Acad Sci U S A 100:6192–6197

    Article  PubMed  CAS  Google Scholar 

  • Cohen DJ, Caprulo BK, Shaywitz BA, Bowers MB Jr (1977) Dopamine and serotonin metabolism in neuropsychiatrically disturbed children: CSF homovanillic acid and 5-hydroxyindoleacetic acid. Arch Gen Psychiatry 34:545–550

    PubMed  CAS  Google Scholar 

  • Cohen DJ, Shaywitz BA, Johnson WT, Bowers MB Jr (1974) Biogenic amines in autistic and atypical children: cerebrospinal fluid measures of homovillic acid and 5-hydroxyindoleacetic acid. Arch Gen Psychiatry 31:845–853

    PubMed  CAS  Google Scholar 

  • Comings DE, Gade R, Muhleman D, Sverd J (1995) No association of a tyrosine hydroxylase gene tetranucleotide repeat polymorphism in autism, Tourette syndrome, or ADHD. Biol Psychiatry 37:484–486

    Article  PubMed  CAS  Google Scholar 

  • Cook EH, Leventhal BL (1996) The serotonin system in autism. Curr Opin Pediatr 8:348–354

    Article  PubMed  CAS  Google Scholar 

  • Cools R (2008) Role of dopamine in the motivational and cognitive control of behavior. Neuroscientist 14:381–395

    Article  PubMed  CAS  Google Scholar 

  • Cooper J, Howell BW (1999) Lipoprotein receptors: signaling function in the brain? Cell 97:671–674

    Article  PubMed  CAS  Google Scholar 

  • Couturier JL, Nicolson R (2002) A retrospective assessment of citalopram in children and adolescents with pervasive developmental disorders. J Child Adolesc Psychopharmacol 12:243–248

    Article  PubMed  Google Scholar 

  • Cross S, Kim SJ, Weiss LA, Delahanty RJ, Sutcliffe JS, Leventhal BL, Cook EH Jr, Veenstra-Vanderweele J (2008) Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism. Neuropsychopharmacology 33:353–360

    Article  PubMed  CAS  Google Scholar 

  • D’Arcangelo G, Homayouni R, Keshvara L, Rice DS, Sheldon M, Curran T (1999) Reelin is a ligand for lipoprotein receptors. Neuron 24:471–479

    Article  PubMed  Google Scholar 

  • Davis E, Fennoy I, Laraque D, Kanem N, Brown G, Mitchell J (1992) Autism and developmental abnormalities in children with perinatal cocaine exposure. J Natl Med Assoc 84:315–319

    PubMed  CAS  Google Scholar 

  • DeBergeyck V, Naerhuyzen B, Goffinet AM, deRouvroit C (1998) A panel of monoclonal antibodies against Reelin, the extracellular matrix protein defective in reeler mutant mice. J Neurosci Methods 82:17–24

    Article  CAS  Google Scholar 

  • de Krom M, Staal WG, Ophoff RA, Hendriks J, Buitelaar J, Franke B, de Jonge MV, Bolton P, Collier D, Curran S, van Engeland H, van Ree JM (2008) A common variant in DRD3 receptor is associated with Autism spectrum disorder. Biol Psychiatry 65(7):625–630

    Article  PubMed  CAS  Google Scholar 

  • DeLong GR, Teague LA, McSwain Kamran M (1998) Effects of fluoxetine treatment in young children with idiopathic autism. Dev Med Child Neurol 40:551–562

    Article  PubMed  CAS  Google Scholar 

  • Devlin B, Bennett P, Dawson G, Figlewicz DA, Grigorenko EL, McMahon W, Minshew N, Pauls D, Smith M, Spence MA, Rodier PM, Stodgell C, Schellenberg GD; CPEA Genetics Network (2004) Alleles of a reelin CGG repeat do not convey liability to autism in a sample from the CPEA network. Am J Med Genet 126B:46–50

    Article  PubMed  Google Scholar 

  • Dhossche D, Applegate H, Abraham A, Maertens P, Bland L, Bencsath A, Martinez J (2002) Elevated plasma gama-aminobutyric acid (GABA) levels in autistic youngsters: stimulus for GABA hypothesis of autism. Med Sci Mon 8:PR1–PR6

    Google Scholar 

  • Dulabon L, Olson EC, Taglienti MG, Eisenhuth S, McGrath B, Walsh CA, Kreidberg JA, Anton ES (2000) Reelin binds alpha 3 beta 1 integrin and inhibits neuronal migration. Neuron 27:33–44

    Article  PubMed  CAS  Google Scholar 

  • Engelmann M, Ebner K, Wotjak CT, Landgraf R (1998) Endogenous oxytocin is involved in short-term olfactory memory in female rats. Behav Brain Res 90:89–94

    Article  PubMed  CAS  Google Scholar 

  • Erlander MG, Tillakaratne NJK, Feldblum S, Patel N, Tobin A (1991) Two genes encode distinct glutamate deoxycarbolases. Neuron 7:97–100

    Article  Google Scholar 

  • Fatemi SH (2008) The hyperglutamatergic hypothesis of autism. Prog Neuropsychopharmacol Biol Psychiatry 32:911

    Article  PubMed  CAS  Google Scholar 

  • Fatemi SH, Folsom TD, Reutiman TJ, Thuras PD (2009a) Expression of GABA(B) receptors is altered in brains of subjects with autism. Cerebellum 8(1):64–69

    Article  PubMed  CAS  Google Scholar 

  • Fatemi SH, Halt A, Stary J, Kanodia R, Schulz SC, Realmuto G (2002a) Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in parietal and cerebellar cortices of autistic subjects. Biol Psychiatry 52:805–810

    Article  PubMed  CAS  Google Scholar 

  • Fatemi SH, Realmuto GM, Khan L, Thuras P (1998) Fluoxetine in treatment of adolescent patients with autism: a longitudinal open trial. J Autism Dev Disord 28:303–307

    Article  PubMed  CAS  Google Scholar 

  • Fatemi SH, Reutiman TJ, Folsom TD, Huang H, Oishi K, Mori S, Smee DF, Pearce DA, Winter C, Sohr R, Juckel G (2008) Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr Res 99:56–70

    Article  PubMed  Google Scholar 

  • Fatemi SH, Reutiman TJ, Folsom TD, Rooney RJ, Patel DH, Thuras P (2010) mRNA and protein levels for GabaAalpha4, alpha5, beta1, and GABABR1 receptors are altered in brains from subjects with autism. J Autism Dev Disord 40:743–750

    Article  PubMed  Google Scholar 

  • Fatemi SH, Reutiman TJ, Folsom TD, Thuras PD (2009b) GABA(A) Receptor Downregulation in Brains of Subjects with Autism. J Autism Dev Disord 39:223–230

    Article  PubMed  Google Scholar 

  • Fatemi SH, Snow AV, Stary JM, Araghi-Niknam M, Brooks AI, Pearce DA, Reutiman TJ, Lee S (2005) Reelin signaling is impaired in autism. Biol Psychiatry 57:777–787

    Article  PubMed  CAS  Google Scholar 

  • Fatemi SH, Stary JM, Egan EA (2002b) Defective Reelin production as a vulnerability factor in genesis of autism. Cell Mol Neurobiol 22:139–152

    Article  PubMed  CAS  Google Scholar 

  • Fatemi SH, Stary JM, Halt AR, Realmuto GR (2001) Dysregulation of Reelin and Bcl-2 proteins in autistic cerebellum. J Autism Dev Disord 6:529–535

    Article  Google Scholar 

  • Ferguson JN, Aldag JM, Insel TR, Young LJ (2001) Oxytocin in the medial amygdala is essential for social recognition in the mouse. J Neurosci 21:8278–8285

    PubMed  CAS  Google Scholar 

  • Ferguson JN, Young LJ, Hearn EF, Matzuk MM, Insel TR, Winslow JT (2000) Social amnesia in mice lacking the oxytocin gene. Nat Genet 25:284–288

    Article  PubMed  CAS  Google Scholar 

  • Forster E, Tielsch A, Saum B, Weiss KH, Johanssen C, Graus-Porta D, Muller U, Frotscher M (2002) Reelin, disabled 1, and beta 1 integrins are required for the formation of the radial glial scaffold in the hippocampus. Proc Natl Acad Sci U S A 99:13178–13183

    Article  PubMed  CAS  Google Scholar 

  • Fox SH, Chuang R, Brotchie JM (2008) Parkinson’s disease–opportunities for novel therapeutics to reduce the problems of levadopa therapy. Prog Brain Res 172:479–494

    Article  PubMed  CAS  Google Scholar 

  • Gillberg C, Svennerholm L (1987) CSF monoamines in autistic syndromes and other pervasive developmental disorders of early childhood. Br J Psychiatry 151:89–94

    Article  PubMed  CAS  Google Scholar 

  • Gillberg C, Svennerholm L, Hamilton-Hellberg C (1983) Childhood psychosis and monoamine metabolites in spinal fluid. J Autism Dev Disord 13:383–396

    Article  PubMed  CAS  Google Scholar 

  • Green L, Fein D, Modahl C, Feinstein C, Waterhouse L, Morris M (2001) Oxytocin and autistic disorder: alterations in peptide forms. Biol Psychiatry 50:609–613

    Article  PubMed  CAS  Google Scholar 

  • Guidotti A, Auta J, Davis JM, Dong E, Grayson DR, Veldic M, Zhang X, Costa E (2005) GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacology (Berl) 180:191–205

    Article  CAS  Google Scholar 

  • Han Y, Qin J, Bu DF, Chang XZ, Yang ZX (2006) Successive alterations of hippocampal gamma-aminobutyric acid B receptor subunits in a rat model of febrile seizure. Life Sci 8:2944–2952

    Article  CAS  Google Scholar 

  • Hardan AY, Handen BL (2002) A retrospective open trial of adjunctive donepezil in children and adolescents with autistic disorder. J Child Adolesc Psychopharmacol 12:237–241

    Article  PubMed  Google Scholar 

  • Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621–2624

    Article  PubMed  CAS  Google Scholar 

  • Hertzman M (2003) Galantamine in the treatment of adult autism: a report of three clinical cases. Int J Psychiatry Med 33:395–398

    Article  PubMed  Google Scholar 

  • Hiesberger T, Trommsdorff M, Howell BW, Goffinet A, Mumby MC, Cooper JA, Herz J (1999) Direct biding of Reelin to VLDL receptor and ApoE receptor 2 induces tyroene phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24:481–489

    Article  PubMed  CAS  Google Scholar 

  • Hohnadel E, Bouchard K, Terry AV Jr (2007) Galantamine and donepezil attenuate pharmacologically induced deficits in prepulse inhibition in rats. Neuropharmacology 52:542–551

    Article  PubMed  CAS  Google Scholar 

  • Hollander E, Bartz J, Chaplin W, Phillips A, Sumner J, Soorya L, Anagnostou E, Wasserman S (2007) Oxytocin increases retention of social cognition in autism. Biol Psychiatry 61:498–503

    Article  PubMed  CAS  Google Scholar 

  • Hollander E, Novotny S, Hanratty M, Yaffe R, DeCaria CM, Aronowitz BR, Mosovich S (2003) Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger’s disorders. Neuropsychopharmacology 28:193–198

    Article  PubMed  CAS  Google Scholar 

  • Hranilović D, Bujas-Petković Z, Tomicić M, Bordukalo-Niksić T, Blazević S, Cicin-Sain L (2009) Hyperserotonemia in autism: activity of 5-HT-associated platelet proteins. J Neural Transm 116:493–501

    Article  PubMed  CAS  Google Scholar 

  • Hranilović D, Novak R, Babić M, Novokmet M, Bujas-Petković Z, Jernej B (2008) Hyperserotonemia in autism: the potential role of 5HT-related gene variants. Coll Antropol 32:75–80

    PubMed  Google Scholar 

  • Huang CH, Santangelo SL (2008) Autism and serotonin transporter gene polymorphisms: a systematic review and meta-analysis. Am J Med Genet B Neuropsychiatr Genet 147B:903–913

    Article  PubMed  Google Scholar 

  • Insel TR, O’Brien DJ, Leckman JF (1999) Oxytocin, vasopressin, and autism: is there a connection? Biol. Psychiatry 45:145–157

    CAS  Google Scholar 

  • Insel TR, Young LJ (2000) Neuropeptides and the evolution of social behavior. Curr Opin Neurobiol 10:784–789

    Article  PubMed  CAS  Google Scholar 

  • Jacob S, Brune CW, Carter CS, Leventhal BL, Lord C, Cook EH Jr (2007) Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism. Neurosci Lett 417:6–9

    Article  PubMed  CAS  Google Scholar 

  • Johnsoton GA, Chebib M, Hanrahan JR, Mewett KN (2003) GABA(C) receptors as drug targets. Curr Drug Targets CNS Neurol Disord 2:260–268

    Article  Google Scholar 

  • Jones KA, Borowsky B, Tamm JA, Craig DA, Durkin MM, Dai M et al (1998) GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 396:674–679

    Article  PubMed  CAS  Google Scholar 

  • Kandel, ER, Schwartz, JH, Jessell, TH (eds) (1995) Essentials of neuroscience and behavior. Appleton and Lange, Norwalk, CT

    Google Scholar 

  • Kramer K, Azmitia EC, Whitaker-Azmitia PM (1994) In vitro release of [3H]5-hydroxytryptamine from fetal and maternal brain by drugs of abuse. Brain Res Dev Brain Res 78:142–146

    Article  PubMed  CAS  Google Scholar 

  • Krebs MO, Betancur C, Leroy S, Bourdel MC, Gillberg C, Leboyer M (2002) Paris Autism Research International Sibpair (PARIS) study. Absence of association between a polymorphic GGC repeat in the 5′ untranslated region of the reelin gene and autism. Mol Psychiatry 7:801–804

    Article  PubMed  CAS  Google Scholar 

  • Kuriyama K, Hirouchi M, Kimura H (2000) Neurochemical and molecular pharmacological aspects of the GABA(B) receptor. Neurochem Res 25:1233–1239

    Article  PubMed  CAS  Google Scholar 

  • Lam KS, Aman MG, Arnold LE (2006) Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil 27:254–289

    Article  PubMed  Google Scholar 

  • Laprade N, Soghomonian JJ (1999) Gene expression of the GAD67 and GAD65 isoforms of glutamate decarboxylase is differently altered in subpopulations of striatal neurons in adult rats lesioned with 6-OHDA as neonates. Synapse 33:36–48

    Article  PubMed  CAS  Google Scholar 

  • Lauritsen MB, Børglum AD, Betancur C, Philippe A, Kruse TA, Leboyer M, Ewald H (2002) Investigation of two variants in the DOPA decarboxylase gene in patients with autism. Am J Med Genet 114:466–470

    Article  PubMed  Google Scholar 

  • Lee M, Martin-Ruiz C, Graham A, Court J, Jaros E, Perry R, Iversen P, Bauman M, Perry E (2002) Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain 125:1483–1495

    Article  PubMed  CAS  Google Scholar 

  • Lerer E, Levi S, Salomon S, Darvasi A, Yirmiya N, Ebstein RP (2008) Association between the oxytocin receptor (OXTR) gene and autism: relationship to Vineland adaptive behavior scales and cognition. Mol Psychiatry 13:980–988

    Article  PubMed  CAS  Google Scholar 

  • Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996) Association of anxiety related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527–1531

    Article  PubMed  CAS  Google Scholar 

  • Li J, Nguyen L, Gleason C, Lotspeich L, Spiker D, Risch N, Myers RM (2004) Lack of evidence for an association between WNT2 and RELN polymorphisms and autism. Am J Med Genet 126B:51–57

    Article  PubMed  Google Scholar 

  • Light KJ, Joyce PR, Luty SE, Mulder RT, Frampton CM, Joyce LR, Miller AL, Kennedy MA (2006) Preliminary evidence for an association between a dopamine D3 receptor gene variant and obsessive-compulsive personality disorder in patients with major depression. Am J Med Genet B Neuropsychiatr Genet 141:409–413

    Google Scholar 

  • Lugli G, Krueger JM, Davis JM, Persico AM, Keller F, Smalheiser NR (2003) Methodological factors influencing measurement and processing of plasma reelin in humans. BMC Biochem 4:9

    Article  PubMed  Google Scholar 

  • Luque JM, Morante-Oria J, Fairen A (2003) Localization of ApoER2, VLDLR and Dab-1 in radial glia: groundwork for a new model of Reelin action during cortical development. Dev Brain Res 140:195–203

    Article  CAS  Google Scholar 

  • Ma DQ, Whitehead PL, Menold MM, Martin ER, Ashley-Koch AE, Mei H, Ritchie MD, Delong GR, Abramson RK, Wright HH, Cuccaro ML, Hussman JP, Gilbert JR, Pericak-Vance MA (2005) Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism. Am J Hum Genet 77:377–388

    Article  PubMed  CAS  Google Scholar 

  • Martin A, Koenig K, Anderson GM, Scahill L (2003) Low-dose fluvoxamine treatment of children and adolescents with pervasive developmental disorders: a prospective, open-label study. J Autism Dev Disord 33:77–85

    Article  PubMed  Google Scholar 

  • Martin-Ruiz CM, Lee M, Perry RH, Baumann M, Court JA, Perry EK (2004) Molecular analysis of nicotinic receptor expression in autism. Brain Res Mol Brain Res 123:81–90

    Article  PubMed  CAS  Google Scholar 

  • Martineau J, Hérault J, Petit E, Guérin P, Hameury L, Perrot A, Mallet J, Sauvage D, Lelord G, Müh JP (1994) Catecholaminergic metabolism and autism. Dev Med Child Neurol 36:688–697

    Article  PubMed  CAS  Google Scholar 

  • McBride PA, Anderson GM, Hertzig ME, Snow ME, Thompson SM, Khait VD, Shapiro T, Cohen DJ (1998) Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation. J Am Acad Child Adolesc Psychiatry 37:767–776

    Article  PubMed  CAS  Google Scholar 

  • McDougle CJ, Naylor ST, Cohen DJ, Aghajanian GK, Heninger GR, Price LH (1996a) Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry 53:993–1000

    PubMed  CAS  Google Scholar 

  • McDougle CJ, Naylor ST, Cohen DJ, Volkmar FR, Heninger GR, Price LH (1996b) A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 53:1001–1008

    PubMed  CAS  Google Scholar 

  • McDougle CJ, Stigler KA, Erickson CA, Posey DJ (2008) Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders. J Clin Psychiatry 69:15–20

    Article  PubMed  CAS  Google Scholar 

  • Minderaa RB, Anderson GM, Volkmar FR, Akkerhuis GW, Cohen DJ (1989) Neurochemical study of dopamine functioning in autistic and normal subjects. J Am Acad Child Adolesc Psychiatry 28:190–194

    Article  PubMed  CAS  Google Scholar 

  • Modahl C, Green L, Fein D, Morris M, Waterhouse L, Feinstein C, Levin H (1998) Plasma oxytocin levels in autistic children. Biol Psychiatry 43:270–277

    Article  PubMed  CAS  Google Scholar 

  • Moore ML, Eichner SF, Jones JR (2004) Treating functional impairment of autism with selective serotonin-reuptake inhibitors. Ann Pharmacother 38:1515–1519

    Article  PubMed  CAS  Google Scholar 

  • Moreno H, Borjas L, Arrieta A, Salz L, Prassad A, Estevez J, Bonilla E (1992) Clinical heterogeneity of the autistic syndrome: a study of 60 families. Invest Clin 33:13–31

    PubMed  CAS  Google Scholar 

  • Moreno-Fuenmayor H, Borjas L, Arrieta A, Valera V, Socorro-Candanoza L (1996) Plasma excitatory amino acids in autism. Invest Clin 37:113–128

    PubMed  CAS  Google Scholar 

  • Narayan M, Srinath S, Anderson GM, Meundi DB (1993) Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism. Biol Psychiatry 33:630–635

    Article  PubMed  CAS  Google Scholar 

  • Nicholson R, Craven-Thuss B, Smith J (2006) A prospective, open-label trial of galantamine in autistic disorder. J Child Adolesc Psychopharmacol 16:621–629

    Article  Google Scholar 

  • Ozaki N, Goldman D, Kaye WH, Plotnicov K, Greenberg BD, Lappalainen J, Rudnick G, Murphy DL (2003) Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry 8(895):933–936

    Article  PubMed  CAS  Google Scholar 

  • Palmen SJ, van Engeland H, Hof PR, Schmitz C (2004) Neuropathological findings in autism. Brain 127:2572–2583

    Article  PubMed  Google Scholar 

  • Pan JW, Lane JB, Hetherington H, Percy AK (1999) Rett Syndrome: H-1 spectroscopic imaging at + 1 Tesla. J Child Neurol 14:524–528

    Article  PubMed  CAS  Google Scholar 

  • Peral M, Alcami M, Gilaberte I (1999) Fluoxetine in children with autism. J Am Acad Child Adolesc Psychiatry 38:1472–1473

    Article  PubMed  CAS  Google Scholar 

  • Perry EK, Lee ML, Martin-Ruiz CM, Court JA, Volsen SG, Merrit J, Folly E, Iversen PE, Bauman ML, Perry RH, Wenk GL (2001) Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am J Psychiatry 158:1058–1066

    Article  PubMed  CAS  Google Scholar 

  • Persico AM, D’Agruma L, Maiorano N, Totaro A, Militerni R, Bravaccio C, Wassink TH, Schneider C, Melmed R, Trillo S, Montecchi F, Palermo M, Pascucci T, Puglisi-Allegra S, Reichelt KL, Conciatori M, Marino R, Quattrocchi CC, Baldi A, Zelante L, Gasparini P, Keller F; Collaborative Linkage Study of Autism (2001) Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol Psychiatry 6:150–159

    Article  PubMed  CAS  Google Scholar 

  • Philippe A, Guilloud-Bataille M, Martinez M, Gillberg C, RÃ¥stam M, Sponheim E, Coleman M, Zappella M, Aschauer H, Penet C, Feingold J, Brice A, Leboyer M; Paris Autism Research International Sibpair Study (2002) Analysis of ten candidate genes in autism by association and linkage. Am J Med Genet 114:125–128

    Article  PubMed  Google Scholar 

  • Popik P, Vetulani J, van Ree JM (1992) Low doses of oxytocin facilitate social recognition in rats. Psychopharmacology (Berl) 106:71–74

    Article  CAS  Google Scholar 

  • Posey DJ, Erickson CA, McDougle CJ (2008) Developing drugs for core social and communication impairment in autism. Child Adolesc Psychiatr Clin N Am 17:787–801

    Article  PubMed  Google Scholar 

  • Princivalle AP, Duncan JS, Thom M, Bowery NG (2003b) GABA(B1a), GABA(B1b) and GABA(B2) mRNA variants expression in hippocampus resected from patients with temporal lobe epilepsy. Neuroscience 122:975–984

    Article  PubMed  CAS  Google Scholar 

  • Princivalle AP, Richards DA, Duncan JS, Spreafico R, Bowery NG (2003a) Modification of GABA(B1) and GABA(B2) receptor subunits in the somatosensory cerebral cortex and thalamus of rats with absence seizures (GAERS). Epilepsy Res 55:39–51

    Article  PubMed  CAS  Google Scholar 

  • Qian H, Ripps H (2008) Focus on molecules: the GABA(C) receptor. Exp Eye Res 88(6):1002–1003

    Article  PubMed  CAS  Google Scholar 

  • Reetz A, Solimena M, Matteoli M, Folli F, Takei K, De Camilli P (1991) GABA and pancreatic beta cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion. EMBO J 10:1275–1284

    PubMed  CAS  Google Scholar 

  • Ross DL, Klykylo WM, Anderson GM (1985) Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism. Ann Neurol 18:394

    Google Scholar 

  • Shemer A, Whitaker-Azmitia PM, Azmitia EC (1988) Effects of prenatal 5-methoxytryptamine and parachlorophenylalanine on serotonergic uptake and behavior in the neonatal rat. Pharmacol Biochem Behav 30:847–851

    Article  PubMed  CAS  Google Scholar 

  • Shi L, Fatemi SH, Sidwell RW, Patterson PH (2003) Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 23:297–302

    PubMed  Google Scholar 

  • Soghomonian JJ, Martin DL (1998) Two isoforms of glutamate decarboxylase: why? Trends Pharmacol Sci 19:500–505

    Article  PubMed  CAS  Google Scholar 

  • Steingard RJ, Zimnitzky B, DeMaso DR, Bauman ML, Bucci JP (1997) Sertraline treatment of transition-associated anxiety and agitation in children with autistic disorder. J Child Adolesc Psychopharmacol 7:9–15

    Article  PubMed  CAS  Google Scholar 

  • Straessle A, Loup F, Arabadzisz D, Ohning GV, Fritschy JM (2003) Rapid and long-term alterations of hippocampal GABAB receptors in a mouse model of temporal lobe epilepsy. Eur J Neurosci 18:2213–2226

    Article  Google Scholar 

  • Strasser V, Fasching D, Hauser C, Mayer H, Bock HH, Hiesberger T, Herz J, Weeber EJ, Sweatt JD, Pramatarova A, Howell B, Schneider WJ, Nimpf J (2004) Receptor clustering is involved in reelin signaling. Mol Cell Biol 24:1378–1386

    Article  PubMed  CAS  Google Scholar 

  • Takayanagi Y, Yoshida M, Bielsky IF, Ross HE, Kawamata M, Onaka T, Yanagisawa T, Kimura T, Matzuk MM, Young LJ, Nishimori K (2005) Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice. Proc Natl Acad Sci U S A 102:16096–16101

    Article  PubMed  CAS  Google Scholar 

  • Tuchman R, Rapin I (2002) Epilepsy in autism. Lancet Neurol 1:352–358

    Article  PubMed  Google Scholar 

  • Waterhouse L, Fein D, Modahl C (1996) Neurofunctional mechanisms in autism. Psychol Rev 103:457–489

    Article  PubMed  CAS  Google Scholar 

  • Weeber EJ, Beffert U, Jones C, Christian JM, Forster E, Sweatt JD, Herz J (2002) Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J Biol Chem 277:39944–39952

    Article  PubMed  CAS  Google Scholar 

  • Whitaker-Azmitia PM (2001) Serotonin and brain development: role in human developmental diseases. Brain Res Bull 56:479–485

    Article  PubMed  CAS  Google Scholar 

  • Whitaker-Azmitia PM (2005) Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism? Int J Dev Neurosci 23:75–83

    Article  PubMed  CAS  Google Scholar 

  • Whitaker-Azmitia PM, Lauder JM, Shemmer A, Azmitia EC (1987) Postnatal changes in serotonin receptors following prenatal alterations in serotonin levels: further evidence for functional fetal serotonin receptors. Brain Res 430:285–289

    PubMed  CAS  Google Scholar 

  • Winsberg BG, Sverd J, Castells S, Hurwic M, Perel JM (1980) Estimation of monoamine and cyclic-AMP turnover and amino acid concentrations of spinal fluid in autistic children. Neuropediatrics 11:250–255

    Article  PubMed  CAS  Google Scholar 

  • Winter C, Reutiman TJ, Folsom TD, Sohr R, Wolf RJ, Juckel G, Fatemi SH (2008) Dopamine and serotonin levels following prenatal viral infection in mouse–implications for psychiatric disorders such as schizophrenia and autism. Eur Neuropsychopharmacol 18:712–716

    Article  PubMed  CAS  Google Scholar 

  • Wu S, Jia M, Ruan Y, Liu J, Guo Y, Shuang M, Gong X, Zhang Y, Yang X, Zhang D (2005) Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population. Biol Psychiatry 58:74–77

    Article  PubMed  CAS  Google Scholar 

  • Yip J, Soghomonian JJ, Blatt GJ (2007) Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications. Acta Neuropathol 113:559–568

    Article  PubMed  CAS  Google Scholar 

  • Ylisaukko-oja T, Alarcón M, Cantor RM, Auranen M, Vanhala R, Kempas E, von Wendt L, Järvelä I, Geschwind DH, Peltonen L (2006) Search for autism loci by combined analysis of autism genetic resource exchange and finnish families. Ann Neurol 59:145–155

    Article  PubMed  Google Scholar 

  • Yrigollen CM, Han SS, Kochetkova A, Babitz T, Chang JT, Volkmar FR, Leckman JF, Grigorenko EL (2008) Genes controlling affiliative behavior as candidate genes for autism. Biol Psychiatry 63:911–916

    Article  PubMed  CAS  Google Scholar 

  • Zhang H, Liu X, Zhang C, Mundo E, Macciardi F, Grayson DR, Guidotti AR, Holden JJ (2002) Reelin gene alleles and susceptibility to autism spectrum disorders. Mol Psychiatry 7:1012–1017

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Grant support by National Institute of Child Health and Human Development (#5R01HD052074-01A2 and #3R01KD052074-03S1) to SHF is gratefully acknowledged

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Hossein Fatemi .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Folsom, T.D., Fatemi, S.H. (2011). Neurochemistry of Autism. In: Blass, J. (eds) Neurochemical Mechanisms in Disease. Advances in Neurobiology, vol 1. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7104-3_13

Download citation

Publish with us

Policies and ethics